Literature DB >> 24306676

A case study of in silico modelling of ciprofloxacin hydrochloride/metallic compound interactions.

Aleksandra Stojkovic1, Jelena Parojcic, Zorica Djuric, Owen I Corrigan.   

Abstract

With the development of physiologically based absorption models, there is an increased scientific and regulatory interest in in silico modelling and simulation of drug-drug and drug-food interactions. Clinically significant interactions between ciprofloxacin and metallic compounds are widely documented. In the current study, a previously developed ciprofloxacin-specific in silico absorption model was employed in order to simulate ciprofloxacin/metallic compound interaction observed in vivo. Commercially available software GastroPlus™ (Simulations Plus Inc., USA) based on the ACAT model was used for gastrointestinal (GI) simulations. The required input parameters, relating to ciprofloxacin hydrochloride physicochemical and pharmacokinetic characteristics, were experimentally determined, taken from the literature or estimated by GastroPlus™. Parameter sensitivity analysis (PSA) was used to assess the importance of selected input parameters (solubility, permeability, stomach and small intestine transit time) in predicting percent drug absorbed. PSA identified solubility and permeability as critical parameters affecting the rate and extent of ciprofloxacin absorption. Using the selected input parameters, it was possible to generate a ciprofloxacin absorption model, without/with metal cation containing preparations co-administration, which matched well the in vivo data available. It was found that reduced ciprofloxacin absorption in the presence of aluminium hydroxide, calcium carbonate or multivitamins/zinc was accounted for by reduced drug solubility. The impact of solubility-permeability interplay on ciprofloxacin absorption can be observed in the ciprofloxacin-aluminium interaction, while in ciprofloxacin-calcium and ciprofloxacin-zinc interactions, effect of solubility was more pronounced. The results obtained indicate that in silico model developed can be successfully used to complement relevant in vitro studies in the simulation of physicochemical ciprofloxacin/metallic compound interactions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24306676      PMCID: PMC3969494          DOI: 10.1208/s12249-013-0055-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  32 in total

Review 1.  Predicting the impact of physiological and biochemical processes on oral drug bioavailability.

Authors:  B Agoram; W S Woltosz; M B Bolger
Journal:  Adv Drug Deliv Rev       Date:  2001-10-01       Impact factor: 15.470

Review 2.  Predicting drug-drug interactions: an FDA perspective.

Authors:  Lei Zhang; Yuanchao Derek Zhang; Ping Zhao; Shiew-Mei Huang
Journal:  AAPS J       Date:  2009-05-06       Impact factor: 4.009

Review 3.  Extravascular penetration of ciprofloxacin. A review.

Authors:  T Bergan
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Mar-Apr       Impact factor: 2.803

4.  Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.

Authors:  K Borner; G Höffken; H Lode; P Koeppe; C Prinzing; P Glatzel; R Wiley; P Olschewski; B Sievers; D Reinitz
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

5.  Pharmacokinetics of intravenous ciprofloxacin at three different doses.

Authors:  B Ljungberg; I Nilsson-Ehle
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

6.  Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule.

Authors:  S Harder; U Fuhr; D Beermann; A H Staib
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

7.  Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers.

Authors:  R E Polk; D P Healy; J Sahai; L Drwal; E Racht
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

8.  Pharmacokinetics of ciprofloxacin after oral and parenteral administration.

Authors:  G Höffken; H Lode; C Prinzing; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

9.  Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.

Authors:  T Bergan; S B Thorsteinsson; I M Kolstad; S Johnsen
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

10.  Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.

Authors:  T A Tartaglione; A C Raffalovich; W J Poynor; A Espinel-Ingroff; T M Kerkering
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

View more
  3 in total

Review 1.  Orally Administered Drug Solubility-Enhancing Formulations: Lesson Learnt from Optimum Solubility-Permeability Balance.

Authors:  Bhakti Mahendra Pawar; Syed Nazrin Ruhina Rahman; Datta Maroti Pawde; Abhinab Goswami; Tamilvanan Shunmugaperumal
Journal:  AAPS PharmSciTech       Date:  2021-02-02       Impact factor: 3.246

2.  Building in-house PBPK modelling tools for oral drug administration from literature information.

Authors:  Silvia Grandoni; Nicola Cesari; Giandomenico Brogin; Paola Puccini; Paolo Magni
Journal:  ADMET DMPK       Date:  2019-02-23

Review 3.  Ayurveda and in silico Approach: A Challenging Proficient Confluence for Better Development of Effective Traditional Medicine Spotlighting Network Pharmacology.

Authors:  Rashmi Sahu; Prashant Kumar Gupta; Amit Mishra; Awanish Kumar
Journal:  Chin J Integr Med       Date:  2022-09-12       Impact factor: 2.626

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.